Prospective study of the burden of rotavirus gastroenteritis in Danish children and their families
- Thomas Hoffmann(corresponding author),
- Miren Iturriza,
- Jens Faaborg-Andersen,
- Christina Kraaer,
- Christina P. Nielsen,
- Jim Gray
- University of Copenhagen,
- Clinic Odense,
- Clinic Fredericia,
- Clinic Roskilde
Research Output:
Contribution to journal
Article
Research
Peer-reviewAbstract
<p>This was the first study to characterize the total burden of rotavirus gastroenteritis (RVGE) at both hospital and general physician (GP) clinics in Denmark, and also the first to confirm rotavirus (RV) as the leading cause of acute gastroenteritis (GE) among children <5 years in GP clinics nationwide. Several aspects of RVGE were reported, including the impact of RVGE on family life by changes in HRQoL and by the number of days absent from day care. RV was detected in 225 (63.6%) children, and the median number of days absent from day care was 5 days. In 43.0% of the families, at least one family member, a total of 170 individuals, experienced symptoms of acute GE. Reduced health-related quality of life was observed both among children and parents. Our data suggested that RVGE indirectly as well as directly is a major public health burden in Denmark and comparable with data from other European countries.</p>
Research Output Information
Output type
Research Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
EnglishPages from-to (Number of pages)
Pages 1535-1539 (5 pages)Journal (Volume, Issue Number)
European Journal of Pediatrics (Volume 170, Issue 12)Publication milestones
- Published - 12/2011
Publication status
Published - 12/2011
ISSN
0340-6199Publication IDs
- Scopus: 82655180897
- PubMed: 21499690
Documents and links
Funding Details
Acknowledgments The authors would like to thank all investigators and study nurses for participating in this study and Sanofi Pasteur MSD ApS, Denmark for financial support. Data collection was done by the investigators. Data processing was performed by an independent CRO.
FunderFunding numbers
Sanofi Pasteur
-Sustainable Development Goals
- SDG 3 Good Health and Well
